Furthermore, in a longitudinal cytotoxicity assay, coexpression of CD8α/β improved the control of A375, a melanoma cell line that endogenously expresses NY-ESO-1 (Fig. 5h and Extended Data Fig. 9d). The gene discussed is CD8A; the disease is melanoma.